Industry Growth Insights published a new data on “Polycystic Ovarian Syndrome (PCOS) Therapeutics Market”. The research report is titled “Polycystic Ovarian Syndrome (PCOS) Therapeutics Market research by Types (Oral Contraceptive, Ovulation Inducing Agents, Facial Hair Growth Inhibitor, Insulin Sensitizing Agent), By Applications (Hospitals, Clinic, Others), By Players/Companies Bristol Myers Squibb, Crinetics Pharmaceuticals, Inc., EffRx, Inc., Ferring Pharmaceuticals, Merck KGaA, Neurocrine Biosciences, Inc., Novartis Pharmaceuticals, Pfizer Inc., Sanofi Aventis, Teva Pharmaceutical Industries Limited”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Research Report
By Type
Oral Contraceptive, Ovulation Inducing Agents, Facial Hair Growth Inhibitor, Insulin Sensitizing Agent
By Application
Hospitals, Clinic, Others
By Companies
Bristol Myers Squibb, Crinetics Pharmaceuticals, Inc., EffRx, Inc., Ferring Pharmaceuticals, Merck KGaA, Neurocrine Biosciences, Inc., Novartis Pharmaceuticals, Pfizer Inc., Sanofi Aventis, Teva Pharmaceutical Industries Limited
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
216
Number of Tables & Figures
152
Customization Available
Yes, the report can be customized as per your need.
Global Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Report Segments:
The global Polycystic Ovarian Syndrome (PCOS) Therapeutics market is segmented on the basis of:
Types
Oral Contraceptive, Ovulation Inducing Agents, Facial Hair Growth Inhibitor, Insulin Sensitizing Agent
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinic, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bristol Myers Squibb
- Crinetics Pharmaceuticals, Inc.
- EffRx, Inc.
- Ferring Pharmaceuticals
- Merck KGaA
- Neurocrine Biosciences, Inc.
- Novartis Pharmaceuticals
- Pfizer Inc.
- Sanofi Aventis
- Teva Pharmaceutical Industries Limited
Highlights of The Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oral Contraceptive
- Ovulation Inducing Agents
- Facial Hair Growth Inhibitor
- Insulin Sensitizing Agent
- By Application:
- Hospitals
- Clinic
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Polycystic Ovarian Syndrome (PCOS) Therapeutics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Polycystic ovary syndrome (PCOS) is a common endocrine disorder that affects about 5% of women of reproductive age. PCOS is characterized by irregular menstrual cycles, elevated levels of testosterone and other hormones, and difficulty getting pregnant. Treatment for PCOS typically includes lifestyle changes such as weight loss, exercise, and reduced stress; medication to lower testosterone levels; or both.
Some of the key players operating in the polycystic ovarian syndrome (pcos) therapeutics market are Bristol Myers Squibb, Crinetics Pharmaceuticals, Inc., EffRx, Inc., Ferring Pharmaceuticals, Merck KGaA, Neurocrine Biosciences, Inc., Novartis Pharmaceuticals, Pfizer Inc., Sanofi Aventis, Teva Pharmaceutical Industries Limited.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Polycystic Ovarian Syndrome (PCOS) Therapeutics Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Polycystic Ovarian Syndrome (PCOS) Therapeutics Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size & Forecast, 2018-2028 4.5.1 Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size and Y-o-Y Growth 4.5.2 Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Absolute $ Opportunity
Chapter 5 Global Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size Forecast by Type
5.2.1 Oral Contraceptive
5.2.2 Ovulation Inducing Agents
5.2.3 Facial Hair Growth Inhibitor
5.2.4 Insulin Sensitizing Agent
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinic
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Polycystic Ovarian Syndrome (PCOS) Therapeutics Analysis and Forecast
9.1 Introduction
9.2 North America Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size Forecast by Type
9.6.1 Oral Contraceptive
9.6.2 Ovulation Inducing Agents
9.6.3 Facial Hair Growth Inhibitor
9.6.4 Insulin Sensitizing Agent
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinic
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Polycystic Ovarian Syndrome (PCOS) Therapeutics Analysis and Forecast
10.1 Introduction
10.2 Europe Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size Forecast by Type
10.6.1 Oral Contraceptive
10.6.2 Ovulation Inducing Agents
10.6.3 Facial Hair Growth Inhibitor
10.6.4 Insulin Sensitizing Agent
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinic
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Polycystic Ovarian Syndrome (PCOS) Therapeutics Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size Forecast by Type
11.6.1 Oral Contraceptive
11.6.2 Ovulation Inducing Agents
11.6.3 Facial Hair Growth Inhibitor
11.6.4 Insulin Sensitizing Agent
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinic
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Polycystic Ovarian Syndrome (PCOS) Therapeutics Analysis and Forecast
12.1 Introduction
12.2 Latin America Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size Forecast by Type
12.6.1 Oral Contraceptive
12.6.2 Ovulation Inducing Agents
12.6.3 Facial Hair Growth Inhibitor
12.6.4 Insulin Sensitizing Agent
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinic
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Polycystic Ovarian Syndrome (PCOS) Therapeutics Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size Forecast by Type
13.6.1 Oral Contraceptive
13.6.2 Ovulation Inducing Agents
13.6.3 Facial Hair Growth Inhibitor
13.6.4 Insulin Sensitizing Agent
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinic
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Polycystic Ovarian Syndrome (PCOS) Therapeutics Market: Competitive Dashboard
14.2 Global Polycystic Ovarian Syndrome (PCOS) Therapeutics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bristol Myers Squibb
14.3.2 Crinetics Pharmaceuticals, Inc.
14.3.3 EffRx, Inc.
14.3.4 Ferring Pharmaceuticals
14.3.5 Merck KGaA
14.3.6 Neurocrine Biosciences, Inc.
14.3.7 Novartis Pharmaceuticals
14.3.8 Pfizer Inc.
14.3.9 Sanofi Aventis
14.3.10 Teva Pharmaceutical Industries Limited